FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roger Pomerantz

Research Profile

Living Beings

Disorders

HIV Infections

Physiology

Chemicals & Drugs

Concepts & Ideas

Molecular Sequence Data

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Zahida Parveen; Edward Acheampong; Roger J Pomerantz; Jeffrey M Jacobson; Brian Wigdahl; Muhammad Mukhtar
Effects of highly active antiretroviral therapy on HIV-1-associated oral complications.
Philip M McKenna; Martin L Koser; Kevin R Carlson; David C Montefiori; Norman L Letvin; Amy Papaneri; Roger J Pomerantz; Bernhard Dietzschold; Peter Silvera; James P McGettigan; Matthias J Schnell
Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
Xiaodong Cheng; Xiandong Cheng; Muhammad Mukhtar; Edward Acheampong; Algarsamy Srinivasan; Mohammad A Rafi; Roger J Pomerantz; Zahida Parveen
HIV-1 Vpr potently induces programmed cell death in the CNS in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roger Pomerantz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Zahida Parveen; Edward Acheampong; Roger J Pomerantz; Jeffrey M Jacobson; Brian Wigdahl; Muhammad Mukhtar
Effects of highly active antiretroviral therapy on HIV-1-associated oral complications.
Current HIV research 2007;5(3):281-92.
2007: Philip M McKenna; Martin L Koser; Kevin R Carlson; David C Montefiori; Norman L Letvin; Amy Papaneri; Roger J Pomerantz; Bernhard Dietzschold; Peter Silvera; James P McGettigan; Matthias J Schnell
Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
The Journal of infectious diseases 2007;195(7):980-8.
2007: Xiaodong Cheng; Xiandong Cheng; Muhammad Mukhtar; Edward Acheampong; Algarsamy Srinivasan; Mohammad A Rafi; Roger J Pomerantz; Zahida Parveen
HIV-1 Vpr potently induces programmed cell death in the CNS in vivo.
DNA and cell biology 2007;26(2):116-31.
2007: Edward Acheampong; Zahida Parveen; Aschalew Mengistu; Noel Ngoubilly; Brian Wigdahl; Albert S Lossinsky; Roger J Pomerantz; Muhammad Mukhtar
Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro.
Journal of virology 2007;81(3):1492-501.
2007: Johanna A Smith; Giuseppe Nunnari; Mirjam Preuss; Roger J Pomerantz; René Daniel
Pentoxifylline suppresses transduction by HIV-1-based vectors.
Intervirology 2007;50(5):377-86.
2006: Elias G Argyris; Geethanjali Dornadula; Giuseppe Nunnari; Edward Acheampong; Chune Zhang; Ketti E Mehlman; Roger J Pomerantz; Hui Zhang
Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.
Virology 2006;353(2):482-90.
2006: Mary Ellen Smith; Martin L Koser; Sa Xiao; Catherine A Siler; James P McGettigan; Catherine Calkins; Roger J Pomerantz; Bernhard Dietzschold; Matthias J Schnell
Rabies virus glycoprotein as a carrier for anthrax protective antigen.
Virology 2006;353(2):344-56.
2006: Rajnish S Dave; James P McGettigan; Tazeen Qureshi; Matthias J Schnell; Giuseppe Nunnari; Roger J Pomerantz
siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
Virology 2006;348(2):489-97.
2005: Giuseppe Nunnari; Roger J Pomerantz
IL-7 as a potential therapy for HIV-1-infected individuals.
Expert opinion on biological therapy 2005;5(11):1421-6.
2005: Saman Kannangara; Joseph A DeSimone; Roger J Pomerantz
Attenuation of HIV-1 infection by other microbial agents.
The Journal of infectious diseases 2005;192(6):1003-9.
2005: Giuseppe Nunnari; Daniela Leto; Julie Sullivan; Yan Xu; Ketti E Mehlman; Joseph Kulkosky; Roger J Pomerantz
Seminal reservoirs during an HIV type 1 eradication trial.
AIDS research and human retroviruses 2005;21(9):768-75.
2005: Giuseppe Nunnari; Yan Xu; Edward Acheampong; Jianhua Fang; Rene Daniel; Chune Zhang; Hui Zhang; Muhammad Mukhtar; Roger J Pomerantz
Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection.
Journal of neurovirology 2005;11(4):319-28.
2005: Giuseppe Nunnari; Julie Sullivan; Yan Xu; Paul Nyirjesy; Joseph Kulkosky; Winston Cavert; Ian Frank; Roger J Pomerantz
HIV type 1 cervicovaginal reservoirs in the era of HAART.
AIDS research and human retroviruses 2005;21(8):714-8.
2005: Edward Acheampong; Zahida Parveen; Lois W Muthoga; Vivian Wasmuth-Peroud; Mehrnush Kalayeh; Adnan Bashir; Robert Diecidue; Muhammad Mukhtar; Roger J Pomerantz
Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.
Journal of virology 2005;79(13):8440-53.
2005: Jianhua Fang; Edward Acheampong; Rajnish S Dave; YONG YANG; Muhammad Mukhtar; Roger J Pomerantz
The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
Virology 2005;336(2):299-307.
2005: David S Strayer; Ramesh Akkina; Bruce A Bunnell; Boro Dropulic; Vicente Planelles; Roger J Pomerantz; John J Rossi; John A Zaia
Current status of gene therapy strategies to treat HIV/AIDS.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(6):823-42.
2005: Giuseppe Nunnari; Elias G Argyris; Jianhua Fang; Ketti E Mehlman; Roger J Pomerantz; René Daniel
Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines.
Virology 2005;335(2):177-84.
2005: Muhammad Mukhtar; Edward Acheampong; Muhammad Khan; Mohamad Bouhamdan; Roger J Pomerantz
Down-modulation of the CXCR4 co-receptor by intracellular expression of a single chain variable fragment (SFv) inhibits HIV-1 entry into primary human brain microvascular endothelial cells and post-mitotic neurons.
Brain research. Molecular brain research 2005;135(1-2):48-57.
2005: Edward Acheampong; Zahida Parveen; Lois W Muthoga; Mehrnush Kalayeh; Muhammad Mukhtar; Roger J Pomerantz
Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases.
Journal of virology 2005;79(7):4257-69.
2005: Wei Chen; Zhonghua Tang; Paolo Fortina; Pritesh Patel; Sankar Addya; Saul Surrey; Edward Acheampong; Muhammad Mukhtar; Roger J Pomerantz
Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways.
Virology 2005;334(1):59-73.
2005: Elena Marusich; Zahida Parveen; David S Strayer; Muhammad Mukhtar; Ralph Dornburg; Roger J Pomerantz
Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection.
Virology 2005;332(1):258-71.
2005: René Daniel; Elena Marusich; Elias G Argyris; Richard Y Zhao; Anna Marie Skalka; Roger J Pomerantz
Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells.
Journal of virology 2005;79(4):2058-65.
2005: Stephen J Scholand; Joseph A DeSimone; Roger J Pomerantz
Anti-HIV-1 microbicides -- 'chemical condoms' designed to limit the scourge of the HIV-1 pandemic.
Current pharmaceutical design 2005;11(29):3747-56.
2005: Muhammad Mukhtar; Edward Acheampong; Zahida Parveen; Roger J Pomerantz
T-Cells and excitotoxicity: HIV-1 and other neurodegenerative disorders.
Neuromolecular medicine 2005;7(3):265-73.
2005: Lalita Chulamokha; Joseph A DeSimone; Roger J Pomerantz
Antiretroviral therapy in the developing world.
Journal of neurovirology 2005;11 Suppl 1():76-80.
2005: Feng-Xiang Wang; Yan Xu; Julie Sullivan; Emily Souder; Elias G Argyris; Edward Acheampong; Jaime Fisher; Maria Sierra; Michael M Thomson; Rafael Najera; Ian Frank; Joseph Kulkosky; Roger J Pomerantz; Giuseppe Nunnari
IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.
The Journal of clinical investigation 2005;115(1):128-37.
2004: Elias G Argyris; Joseph Kulkosky; Marie E Meyer; Yan Xu; Muhammad Mukhtar; Roger J Pomerantz; Kevin Jon Williams
The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity.
Virology 2004;330(2):481-6.
2004: Jianhua Fang; Satoshi Kubota; Bin Yang; Naiming Zhou; Hui Zhang; Roseline Godbout; Roger J Pomerantz
A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
Virology 2004;330(2):471-80.
2004: Rajnish S Dave; Roger J Pomerantz
Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
Journal of virology 2004;78(24):13687-96.
2004: Philip M McKenna; Pyone Aye; Bernhard Dietzschold; David C Montefiori; Louis N Martin; Preston A Marx; Roger J Pomerantz; Andrew Lackner; Matthias J Schnell
Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque.
Journal of virology 2004;78(24):13455-9.
2004: Naiming Zhou; Jianhua Fang; Muhammad Mukhtar; Edward Acheampong; Roger J Pomerantz
Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
Gene therapy 2004;11(23):1703-12.
2004: Roger J Pomerantz
RNA interference:a potential novel therapeutic combating HIV-1 in the central nervous system.
Archivum immunologiae et therapiae experimentalis 2004;52(6):401-9.
2004: Pierre Cordelier; J W Kulkowsky; C Ko; A A Matskevitch; Hayley J McKee; John J Rossi; Mohamad Bouhamdan; Roger J Pomerantz; G Kari; David S Strayer
Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
Gene therapy 2004;11(22):1627-37.
2004: Roger J Pomerantz
Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradication.
Archivum immunologiae et therapiae experimentalis 2004;52(5):297-306.
2004: Zahida Parveen; Muhammad Mukhtar; Adrienne Goodrich; Edward Acheampong; Ralph Dornburg; Roger J Pomerantz
Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.
Journal of virology 2004;78(12):6480-8.
2004: Yan Xu; Joseph Kulkosky; Edward Acheampong; Giuseppe Nunnari; Julie Sullivan; Roger J Pomerantz
HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(18):7070-5.
2004: Joseph Kulkosky; Julie Sullivan; Yan Xu; Emily Souder; Dean H Hamer; Roger J Pomerantz
Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents.
AIDS research and human retroviruses 2004;20(5):497-505.
2004: Roger J Pomerantz
Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis.
DNA and cell biology 2004;23(4):227-38.
2004: Elias G Argyris; Roger J Pomerantz
HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host.
Trends in microbiology 2004;12(4):145-8.
2004: Adrienne Goodrich; Zahida Parveen; Ralph Dornburg; Matthias J Schnell; Roger J Pomerantz
Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(4):557-65.
2004: Roger J Pomerantz; Giuseppe Nunnari
HIV and GB virus C--can two viruses be better than one?
The New England journal of medicine 2004;350(10):963-5.
2003: Naiming Zhou; Xiaoling Zhang; Xuejun Fan; Elias G Argyris; Jianhua Fang; Edward Acheampong; Garrett C DuBois; Roger J Pomerantz
The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity.
Virology 2003;317(1):84-94.
2003: Joseph A DeSimone; Timothy Babinchak; Kris R Kaulback; Roger J Pomerantz
Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals.
AIDS patient care and STDs 2003;17(12):617-22.
2003: Giuseppe Nunnari; Luciano Nigro; Filippo Palermo; Daniela Leto; Roger J Pomerantz; Bruno Cacopardo
Reduction of serum melatonin levels in HIV-1-infected individuals' parallel disease progression: correlation with serum interleukin-12 levels.
Infection 2003;31(6):379-82.
2003: Miguel Otero; Giuseppe Nunnari; Daniela Leto; Julie Sullivan; Feng-Xiang Wang; Ian Frank; Yan Xu; Charvi Patel; Geethanjali Dornadula; Joseph Kulkosky; Roger J Pomerantz
Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
AIDS research and human retroviruses 2003;19(12):1097-103.
2003: Philip M McKenna; Roger J Pomerantz; Bernhard Dietzschold; James P McGettigan; Matthias J Schnell
Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.
Journal of virology 2003;77(23):12782-94.
2003: Rajnish S Dave; Roger J Pomerantz
RNA interference: on the road to an alternate therapeutic strategy!
Reviews in medical virology 2003;13(6):373-85.
2003: Elias G Argyris; Edward Acheampong; Giuseppe Nunnari; Muhammad Mukhtar; Kevin Jon Williams; Roger J Pomerantz
Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts.
Journal of virology 2003;77(22):12140-51.
2003: Roger J Pomerantz
The HIV-1 Vif protein: a paradigm for viral:cell interactions.
Cellular and molecular life sciences : CMLS 2003;60(10):2017-9.
2003: Joseph Kulkosky; Julie Sullivan; Yan Xu; Anne Malin-Markham; Miguel Otero; Sandra A Calarota; Jennifer Zielinski; Derek M Culnan; Roger J Pomerantz
Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo.
Virology 2003;314(2):617-29.
2003: Zahida Parveen; Muhammad Mukhtar; Mohammad A Rafi; David A Wenger; Khwaja M Siddiqui; Catherine A Siler; Bernhard Dietzschold; Roger J Pomerantz; Matthias J Schnell; Ralph Dornburg
Cell-type-specific gene delivery into neuronal cells in vitro and in vivo.
Virology 2003;314(1):74-83.
2003: Xuejun Fan; Naiming Zhou; Xiaoling Zhang; Muhammad Mukhtar; Zhixian Lu; Jianhua Fang; Garrett C DuBois; Roger J Pomerantz
Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ.
Biochemistry 2003;42(34):10163-8.
2003: Pierre Cordelier; Sandra A Calarota; Roger J Pomerantz; Jiang Xiaoshan; David S Strayer
Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2003;23(9):477-88.
2003: Naiming Zhou; Jianhua Fang; Edward Acheampong; Muhammad Mukhtar; Roger J Pomerantz
Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1.
Virology 2003;312(1):196-203.
2003: Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.
Nature 2003;424(6944):94-8.
2003: Roger J Pomerantz; David L Horn
Twenty years of therapy for HIV-1 infection.
Nature medicine 2003;9(7):867-73.
2003: Giuseppe Nunnari; Luciano Nigro; Filippo Palermo; Massimo Attanasio; Annemarie Berger; Hans W Doerr; Roger J Pomerantz; Bruno Cacopardo
Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile.
Annals of internal medicine 2003;139(1):26-30.
2003: Philip M McKenna; James P McGettigan; Roger J Pomerantz; Bernhard Dietzschold; Matthias J Schnell
Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases.
Current HIV research 2003;1(2):229-37.
2003: Roger J Pomerantz
Immune reconstitution syndrome in AIDS. Interview by Vicki Glaser.
AIDS patient care and STDs 2003;17(3):99-101.
2003: Roger J Pomerantz
Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1.
HIV clinical trials 2003;4(2):137-43.
2003: Naiming Zhou; Xuejun Fan; Muhammad Mukhtar; Jianhua Fang; Charvi A Patel; Garrett C DuBois; Roger J Pomerantz
Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ.
Virology 2003;307(1):22-36.
2003: Bin Yang; Ling Gao; Lin Li; Zhixian Lu; Xuejun Fan; Charvi A Patel; Roger J Pomerantz; Garrett C DuBois; Hui Zhang
Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.
The Journal of biological chemistry 2003;278(8):6596-602.
2003: Michele Di Mascio; Geethanjali Dornadula; Hui Zhang; Julie Sullivan; Yan Xu; Joseph Kulkosky; Roger J Pomerantz; Alan S Perelson
In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months.
Journal of virology 2003;77(3):2271-5.
2003: James P McGettigan; Roger J Pomerantz; Catherine A Siler; Philip M McKenna; Heather Foley Malicki; Bernhard Dietzschold; Matthias J Schnell
Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic.
Journal of virology 2003;77(1):237-44.
2003: Edward Acheampong; Miguel Rosario-Otero; Ralph Dornburg; Roger J Pomerantz
Replication of lentiviruses.
Frontiers in bioscience : a journal and virtual library 2003;8():s156-74.
2002: Edward Acheampong; Muhammad Mukhtar; Zahida Parveen; Noel Ngoubilly; Navid Ahmad; Charvi Patel; Roger J Pomerantz
Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells.
Virology 2002;304(2):222-34.
2002: Joseph Kulkosky; Roger J Pomerantz
Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(12):1520-6.
2002: Joseph Kulkosky; Giuseppe Nunnari; Miguel Otero; Sandra A Calarota; Geethanjali Dornadula; Hui Zhang; Anne Malin; Julie Sullivan; Yan Xu; Joseph DeSimone; Timothy Babinchak; John Stern; Winston Cavert; Ashley Haase; Roger J Pomerantz
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy.
The Journal of infectious diseases 2002;186(10):1403-11.
2002: Roger J Pomerantz
Clinical HIV-1 virology.
Clinics in laboratory medicine 2002;22(3):xi-xiii.
2002: Roger J Pomerantz
HIV-1 reservoirs.
Clinics in laboratory medicine 2002;22(3):651-80, vi.
2002: Joseph A DeSimone; Roger J Pomerantz
New methods for the detection of HIV.
Clinics in laboratory medicine 2002;22(3):573-92, v.
2002: Roger J Pomerantz
Eliminating HIV-1 reservoirs.
Current opinion in investigational drugs (London, England : 2000) 2002;3(8):1133-7.
2002: Jianhua Fang; Satoshi Kubota; Roger J Pomerantz
A trans-dominant negative HIV type 1 Rev with intact domains of NLS/NOS and NES.
AIDS research and human retroviruses 2002;18(10):705-9.
2002: Arunima Mamidi; Joseph A DeSimone; Roger J Pomerantz
Central nervous system infections in individuals with HIV-1 infection.
Journal of neurovirology 2002;8(3):158-67.
2002: Muhammad Mukhtar; Steve Harley; Peiqin Chen; Mohamad Bouhamdan; Charvi Patel; Edward Acheampong; Roger J Pomerantz
Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN.
Virology 2002;297(1):78-88.
2002: Charvi A Patel; Muhammad Mukhtar; Stephen Harley; Joseph Kulkosky; Roger J Pomerantz
Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons.
Journal of neurovirology 2002;8(2):86-99.
2002: Catherine A Siler; James P McGettigan; Bernhard Dietzschold; Steven K Herrine; Jean Dubuisson; Roger J Pomerantz; Matthias J Schnell
Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
Virology 2002;292(1):24-34.
2002: Giuseppe Nunnari; Miguel Otero; Geethanjali Dornadula; Michelle Vanella; Hui Zhang; Ian Frank; Roger J Pomerantz
Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections.
AIDS (London, England) 2002;16(1):39-45.
2002: David S Strayer; Francisco Branco; Julien Landré; Mohamad Bouhamdan; Farida Shaheen; Roger J Pomerantz
Combination genetic therapy to inhibit HIV-1.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(1):33-41.
2002: Heather Foley Malicki; Miguel Otero; Jan M Orenstein; Roger J Pomerantz; Matthias J Schnell
Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells.
Journal of virology 2002;76(1):19-31.
2002: Roger J Pomerantz
Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(1):91-7.
2001: Naiming Zhou; Zhaowen Luo; Jiansong Luo; Dongxiang Liu; JW Hall; Roger J Pomerantz; Ziwei Huang
Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.
The Journal of biological chemistry 2001;276(46):42826-33.
2001: Joseph Kulkosky; Derek M Culnan; J Roman; Geethanjali Dornadula; Matthias J Schnell; M R Boyd; Roger J Pomerantz
Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.
Blood 2001;98(10):3006-15.
2001: James P McGettigan; S Sarma; J M Orenstein; Roger J Pomerantz; Matthias J Schnell
Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
Journal of virology 2001;75(18):8724-32.
2001: G C Jayan; Pierre Cordelier; Charvi Patel; Mohamad Bouhamdan; R P Johnson; Julianna Lisziewicz; Roger J Pomerantz; David S Strayer
SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Gene therapy 2001;8(13):1033-42.
2001: Geethanjali Dornadula; Giuseppe Nunnari; M Vanella; J Roman; Timothy Babinchak; Joseph DeSimone; John Stern; M Braffman; Hui Zhang; Roger J Pomerantz
Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.
The Journal of infectious diseases 2001;183(11):1682-7.
2001: James P McGettigan; Heather Foley Malicki; I M Belyakov; J A Berzofsky; Roger J Pomerantz; Matthias J Schnell
Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.
Journal of virology 2001;75(9):4430-4.
2001: Mohamad Bouhamdan; David S Strayer; D Wei; Muhammad Mukhtar; LX Duan; J Hoxie; Roger J Pomerantz
Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.
Gene therapy 2001;8(5):408-18.
2000: Muhammad Mukhtar; Roger J Pomerantz
Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection.
Journal of human virology 2000;3(6):324-34.
2000: Charvi A Patel; Muhammad Mukhtar; Roger J Pomerantz
Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells.
Journal of virology 2000;74(20):9717-26.
2000: Joseph A DeSimone; Roger J Pomerantz; Timothy Babinchak
Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.
Annals of internal medicine 2000;133(6):447-54.
2000: Hui Zhang; Roger J Pomerantz; Geethanjali Dornadula; Y Sun
Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
Journal of virology 2000;74(18):8252-61.
2000: Satoshi Kubota; Roger J Pomerantz
The nuclear function of the nuclear diffusion inhibitory signal of human immunodeficiency virus type 1: critical roles in dominant nuclear localization and intracellular stability.
Journal of human virology 2000;3(4):173-81.
2000: Zahida Parveen; A Krupetsky; Martin Engelstädter; Klaus Cichutek; Roger J Pomerantz; Ralph Dornburg
Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells.
Nature biotechnology 2000;18(6):623-9.
2000: Joseph Kulkosky; Mohamad Bouhamdan; A Geist; Giuseppe Nunnari; D G Phinney; Roger J Pomerantz
Pathogenesis of HIV-1 infection within bone marrow cells.
Leukemia & lymphoma 2000;37(5-6):497-515.
2000: H Zhang; Geethanjali Dornadula; J Orenstein; Roger J Pomerantz
Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.
Journal of human virology 2000;3(3):165-72.
2000: David S Strayer; Roger J Pomerantz; M Yu; M Rosenzweig; Mohamad Bouhamdan; SV Yurasov; R P Johnson; Harris Goldstein
Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
Gene therapy 2000;7(10):886-95.
2000: Matthias J Schnell; Heather Foley Malicki; Catherine A Siler; James P McGettigan; Bernhard Dietzschold; Roger J Pomerantz
Recombinant rabies virus as potential live-viral vaccines for HIV-1.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(7):3544-9.
2000: Geethanjali Dornadula; S Yang; Roger J Pomerantz; Hui Zhang
Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription.
Journal of virology 2000;74(6):2594-602.
2000: Muhammad Mukhtar; H Duke; Mohamad Bouhamdan; Roger J Pomerantz
Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir.
Human gene therapy 2000;11(2):347-59.
2000: Ralph Dornburg; Roger J Pomerantz
HIV-1 gene therapy: promise for the future.
Advances in pharmacology (San Diego, Calif.) 2000;49():229-61.
2000: Mohamad Bouhamdan; Joseph Kulkosky; LX Duan; Roger J Pomerantz
Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
Journal of human virology 2000;3(1):6-15.
1999: Geethanjali Dornadula; Hui Zhang; B VanUitert; John Stern; Lawrence L Livornese; M J Ingerman; J Witek; R J Kedanis; J Natkin; Joseph DeSimone; Roger J Pomerantz
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
JAMA : the journal of the American Medical Association 1999;282(17):1627-32.
1999: A Jiang; H Fisher; Roger J Pomerantz; Ralph Dornburg
A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
Human gene therapy 1999;10(16):2627-36.
1999: Iwata Ozaki; Mark A Zern; S Liu; D L Wei; Roger J Pomerantz; L Duan
Ribozyme-mediated specific gene replacement of the alpha1-antitrypsin gene in human hepatoma cells.
Journal of hepatology 1999;31(1):53-60.
1999: I Agostini; Jean-Marc Navarro; Mohamad Bouhamdan; KE Willetts; Félix A Rey; B Spire; Robert Vigne; Roger J Pomerantz; Joséphine Sire
The HIV-1 Vpr co-activator induces a conformational change in TFIIB.
FEBS letters 1999;450(3):235-9.
1999: S Kubota; H Zhang; S Kitahara; Roger J Pomerantz
Role of lentiviral lytic polypeptide I (LLP-I) in the selective cytotoxicity of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1-producing cells.
Antiviral chemistry & chemotherapy 1999;10(3):121-7.
1999: F Shaheen; A V Sison; L McIntosh; Muhammad Mukhtar; Roger J Pomerantz
Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
Journal of human virology 1999;2(3):154-66.
1999: Mohamad Bouhamdan; LX Duan; Roger J Pomerantz; David S Strayer
Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
Gene therapy 1999;6(4):660-6.
1999: Joseph Kulkosky; A Laptev; S Shetty; A Srinivasan; Mohamad Bouhamdan; D J Prockop; Roger J Pomerantz
Human immunodeficiency virus type 1 Vpr alters bone marrow cell function.
Blood 1999;93(6):1906-15.
1999: Joseph Kulkosky; Mohamad Bouhamdan; A Geist; Roger J Pomerantz
A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.
Virology 1999;255(1):77-85.
1999: Satoshi Kubota; T D Copeland; Roger J Pomerantz
Nuclear and nucleolar targeting of human ribosomal protein S25: common features shared with HIV-1 regulatory proteins.
Oncogene 1999;18(7):1503-14.
1999: Geethanjali Dornadula; Hui Zhang; S Shetty; Roger J Pomerantz
HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission.
Virology 1999;253(1):10-6.
1999: Mark A Zern; Iwata Ozaki; L Duan; Roger J Pomerantz; S L Liu; D S Strayer
A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line.
Gene therapy 1999;6(1):114-20.
1998: Hui Zhang; Geethanjali Dornadula; M Beumont; Lawrence L Livornese; B Van Uitert; K Henning; Roger J Pomerantz
Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
The New England journal of medicine 1998;339(25):1803-9.
1998: Hui Zhang; Geethanjali Dornadula; Roger J Pomerantz
Natural endogenous reverse transcription of HIV-1.
Journal of reproductive immunology 1998;41(1-2):255-60.
1998: S F Zhao; W Li; G Dornadula; D Dicker; J Hoxie; Stephen Peiper; Roger J Pomerantz; LX Duan
Chemokine receptors and the molecular basis for human immunodeficiency virus type 1 entry into peripheral hematopoietic stem cells and their progeny.
The Journal of infectious diseases 1998;178(6):1623-34.
1998: LX Duan; M A Laughlin; J W Oakes; Roger J Pomerantz
Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(17):10344.
1998: Satoshi Kubota; Roger J Pomerantz
A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins.
Oncogene 1998;16(14):1851-61.
1998: Mohamad Bouhamdan; Y Xue; Y Baudat; Baocheng Hu; Joséphine Sire; Roger J Pomerantz; LX Duan
Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins.
The Journal of biological chemistry 1998;273(14):8009-16.
1998: H Zhang; Geethanjali Dornadula; Roger J Pomerantz
Natural endogenous reverse transcription of HIV type 1.
AIDS research and human retroviruses 1998;14 Suppl 1():S93-5.
1998: Satoshi Kubota; RA Furuta; M Hatanaka; Roger J Pomerantz
Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
Biochemical and biophysical research communications 1998;243(1):79-85.
1997: L Duan; M Zhu; Iwata Ozaki; Hui Zhang; D L Wei; Roger J Pomerantz
Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
Gene therapy 1997;4(6):533-43.
1997: Omar Bagasra; Lisa Bobroski; A Sarker; Alexander U Bagasra; P Saikumari; Roger J Pomerantz
Absence of the inducible form of nitric oxide synthase in the brains of patients with the acquired immunodeficiency syndrome.
Journal of neurovirology 1997;3(2):153-67.
1997: Geethanjali Dornadula; Hui Zhang; Omar Bagasra; Roger J Pomerantz
Natural endogenous reverse transcription of simian immunodeficiency virus.
Virology 1997;227(1):260-7.
1997: Omar Bagasra; Muhammad Mukhtar; F Shaheen; Roger J Pomerantz
In situ PCR. Current protocol.
Methods in molecular biology (Clifton, N.J.) 1997;63():275-303.
1996: P Levy-Mintz; LX Duan; Hui Zhang; B Hu; Geethanjali Dornadula; M Zhu; Joseph Kulkosky; D Bizub-Bender; Anna Marie Skalka; Roger J Pomerantz
Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase.
Journal of virology 1996;70(12):8821-32.
1996: William J Harrington; Omar Bagasra; C E Sosa; Lisa Bobroski; M Baum; X L Wen; Lisa Cabral; Gerald E Byrne; Roger J Pomerantz; Charles Wood
Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients.
The Journal of infectious diseases 1996;174(5):1101-5.
1996: Hui Zhang; Geethanjali Dornadula; P Alur; M A Laughlin; Roger J Pomerantz
Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(22):12519-24.
1996: M Zhu; LX Duan; Roger J Pomerantz
TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells.
AIDS research and human retroviruses 1996;12(12):1093-101.
1996: Muhammad Mukhtar; LX Duan; Omar Bagasra; Roger J Pomerantz
Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Gene therapy 1996;3(8):725-30.
1996: M Niikura; Geethanjali Dornadula; Hui Zhang; Muhammad Mukhtar; D Lingxun; Kamel Khalili; Omar Bagasra; Roger J Pomerantz
Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
Oncogene 1996;13(2):313-22.
1996: Satoshi Kubota; M Hatanaka; Roger J Pomerantz
Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein: alterations by coexpression of the HTLV-I p21x protein.
Virology 1996;220(2):502-7.
1996: Omar Bagasra; E Lavi; Lisa Bobroski; Kamel Khalili; J P Pestaner; R Tawadros; Roger J Pomerantz
Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.
AIDS (London, England) 1996;10(6):573-85.
1996: F Shaheen; LX Duan; M Zhu; Omar Bagasra; Roger J Pomerantz
Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.
Journal of virology 1996;70(6):3392-400.
1996: Y Wu; LX Duan; M Zhu; B Hu; Satoshi Kubota; Omar Bagasra; Roger J Pomerantz
Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition.
Journal of virology 1996;70(5):3290-7.
1996: Hui Zhang; Geethanjali Dornadula; Roger J Pomerantz
Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.
Journal of virology 1996;70(5):2809-24.
1996: Satoshi Kubota; H Siomi; M Hatanaka; Roger J Pomerantz
Cis/trans-activation of the interleukin-9 receptor gene in an HTLV-I-transformed human lymphocytic cell.
Oncogene 1996;12(7):1441-7.
1996: Omar Bagasra; S E Bachman; L Jew; R Tawadros; J Cater; G Boden; I Ryan; Roger J Pomerantz
Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: potential immunopathogenic mechanisms.
The Journal of infectious diseases 1996;173(3):550-8.
1996: Satoshi Kubota; LX Duan; R A Furuta; M Hatanaka; Roger J Pomerantz
Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein.
Journal of virology 1996;70(2):1282-7.
1996: Hui Zhang; Geethanjali Dornadula; Y Wu; D Havlir; D D Richman; Roger J Pomerantz
Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo.
Journal of virology 1996;70(1):628-34.
1995: LX Duan; M Zhu; Omar Bagasra; Roger J Pomerantz
Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
Human gene therapy 1995;6(12):1561-73.
1995: M Kundu; Alagarsamy Srinivasan; Roger J Pomerantz; Kamel Khalili
Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
Journal of virology 1995;69(11):6940-6.
1995: M A Laughlin; G Y Chang; J W Oakes; F Gonzalez-Scarano; Roger J Pomerantz
Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kappa B.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;9(4):332-9.
1995: Hui Zhang; LX Duan; Geethanjali Dornadula; Roger J Pomerantz
Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies.
Journal of virology 1995;69(6):3929-32.
1995: J. Paul Taylor; Roger J Pomerantz; J W Oakes; Kamel Khalili; Shohreh Amini
A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
Oncogene 1995;10(2):395-400.
1995: M. Nasar Qureshi; C E Barr; T Seshamma; J Reidy; Roger J Pomerantz; Omar Bagasra
Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons.
The Journal of infectious diseases 1995;171(1):190-3.
1994: LX Duan; Roger J Pomerantz
Elimination of endogenous aberrant kappa chain transcripts from sp2/0-derived hybridoma cells by specific ribozyme cleavage: utility in genetic therapy of HIV-1 infections.
Nucleic acids research 1994;22(24):5433-8.
1994: Omar Bagasra; Homayoon Farzadegan; T Seshamma; J W Oakes; Alfred J Saah; Roger J Pomerantz
Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men.
AIDS (London, England) 1994;8(12):1669-74.
1994: Hui Zhang; Omar Bagasra; M Niikura; B J Poiesz; Roger J Pomerantz
Intravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals.
Journal of virology 1994;68(11):7591-7.
1994: LX Duan; Hui Zhang; J W Oakes; Omar Bagasra; Roger J Pomerantz
Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains.
Human gene therapy 1994;5(11):1315-24.
1994: J W Oakes; Omar Bagasra; LX Duan; Roger J Pomerantz
Association of alterations in NF-kappa B moieties with HIV type 1 proviral latency in certain monocytic cells.
AIDS research and human retroviruses 1994;10(10):1213-9.
1994: LX Duan; Iwata Ozaki; J W Oakes; J. Paul Taylor; Kamel Khalili; Roger J Pomerantz
The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.
Journal of virology 1994;68(7):4302-13.
1994: J. Paul Taylor; Roger J Pomerantz; Ganesh V Raj; Fatah Kashanchi; John N Brady; Shohreh Amini; Kamel Khalili
Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.
Journal of virology 1994;68(6):3971-81.
1994: O Bagasra; Roger J Pomerantz
In situ polymerase chain reaction and HIV-1.
Clinics in laboratory medicine 1994;14(2):351-65.
1994: M A Laughlin; Roger J Pomerantz
Cellular latency in HIV-1 infection.
Clinics in laboratory medicine 1994;14(2):239-55.
1994: LX Duan; Omar Bagasra; M A Laughlin; J W Oakes; Roger J Pomerantz
Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(11):5075-9.
1994: LX Duan; J W Oakes; A Ferraro; Omar Bagasra; Roger J Pomerantz
Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
Virology 1994;199(2):474-8.
1993: Omar Bagasra; Roger J Pomerantz
Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine.
The Journal of infectious diseases 1993;168(5):1157-64.
1993: Omar Bagasra; T Seshamma; J W Oakes; Roger J Pomerantz
Frequency of cells positive for HIV-1 sequences assessed by in situ polymerase chain reaction.
AIDS (London, England) 1993;7 Suppl 2():S7-10.
1993: Omar Bagasra; T Seshamma; J W Oakes; Roger J Pomerantz
High percentages of CD4-positive lymphocytes harbor the HIV-1 provirus in the blood of certain infected individuals.
AIDS (London, England) 1993;7(11):1419-25.
1993: M A Laughlin; S Zeichner; Dennis L Kolson; James C Alwine; T Seshamma; Roger J Pomerantz; F Gonzalez-Scarano
Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA.
Virology 1993;196(2):496-505.
1993: Omar Bagasra; Andre A. Kajdacsy-Balla; HW Lischner; Roger J Pomerantz
Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells.
The Journal of infectious diseases 1993;167(4):789-97.
1993: Omar Bagasra; T Seshamma; Roger J Pomerantz
Polymerase chain reaction in situ: intracellular amplification and detection of HIV-1 proviral DNA and other specific genes.
Journal of immunological methods 1993;158(1):131-45.
1993: Omar Bagasra; Roger J Pomerantz
Human immunodeficiency virus type I provirus is demonstrated in peripheral blood monocytes in vivo: a study utilizing an in situ polymerase chain reaction.
AIDS research and human retroviruses 1993;9(1):69-76.
1992: Omar Bagasra; Kamel Khalili; T Seshamma; J. Paul Taylor; Roger J Pomerantz
TAR-independent replication of human immunodeficiency virus type 1 in glial cells.
Journal of virology 1992;66(12):7522-8.
1992: T Seshamma; Omar Bagasra; J W Oakes; Roger J Pomerantz
A quantitative reverse transcriptase-polymerase chain reaction for HIV-1-specific RNA species.
Journal of virological methods 1992;40(3):331-45.
1992: T Seshamma; Omar Bagasra; D Trono; David Baltimore; Roger J Pomerantz
Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(22):10663-7.
1992: Omar Bagasra; S D Wright; T Seshamma; J W Oakes; Roger J Pomerantz
CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(14):6285-9.
1992: Omar Bagasra; S P Hauptman; HW Lischner; M Sachs; Roger J Pomerantz
Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction.
The New England journal of medicine 1992;326(21):1385-91.
1992: Roger J Pomerantz; T Seshamma; D Trono
Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency.
Journal of virology 1992;66(3):1809-13.
1991: Omar Bagasra; P Whittle; B Heins; Roger J Pomerantz
Anti-human immunodeficiency virus type 1 activity of sulfated monosaccharides: comparison with sulfated polysaccharides and other polyions.
The Journal of infectious diseases 1991;164(6):1082-90.